>>Signaling Pathways>> Others>> Negative Controls>>4α-Phorbol 12-myristate 13-acetate

4α-Phorbol 12-myristate 13-acetate (Synonyms: 4α-PMA)

Catalog No.GC18535

4α-Phorbol 12-myristate 13-acetate는 TPA의 비활성 형태이며 TPA 활성화 이벤트에 대한 음성 대조군으로 사용됩니다.

Products are for research use only. Not for human use. We do not sell to patients.

4α-Phorbol 12-myristate 13-acetate Chemical Structure

Cas No.: 63597-44-4

Size 가격 재고 수량
1mg
US$102.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 2 publications

Description Chemical Properties Product Documents Related Products

Phorbol 12-myristate 13-acetate is a phorbol ester that is commonly used to activate certain types of PKC, including group A (α, βI, βII, γ) and group B (δ, ε, η, θ) isoforms. 4α-PMA is a structural analog of PMA that does not activate PKC. It is used as a negative control for PMA signaling through PKC.

References:
[1]. Blumberg, P.M. Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth Rhoads Memorial Award Lecture Cancer Research 48(1), 1-8 (1988).
[2]. Fischer, S.M., Patrick, K.E., Lee, M.L., et al. 4β- and 4α-12-O-tetradecanoylphorbol-13-acetate elicit arachidonate release from epidermal cells through different mechanisms Cancer Res. 51(3), 850-856 (1991).
[3]. Savage, M.J., Trusko, S.P., Howland, D.S., et al. Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester Journal of Neuroscience 18(5), 1743-1752 (1998).

리뷰

Review for 4α-Phorbol 12-myristate 13-acetate

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 4α-Phorbol 12-myristate 13-acetate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.